← Leaderboards
Sheri L. Holmen
Utah State Higher Education System--University Of Utah
$10,554,952
Attributed
$11,067,773
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $911.2K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,067,773 · 7
By mechanism
R01$9,421,346 · 4
T32$769,232 · 1
P30$485,079 · 1
R21$392,116 · 1
Top collaborators
- Donald E Ayer3 shared
- Sean Vahram Tavtigian3 shared
Most similar at Utah State Higher Education System--University Of Utah
Same institution · by research overlap
- Alessandra Angelucci$14,407,809
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsMouse ModelIncidenceSamplingPathway InteractionsAdultMutationIn VivoMutantProteinsSignal TransductionGenesNeoplasm MetastasisGrowthPre-Clinical ModelMolecularCessation Of LifeCellsResponseNovel TherapeuticsBiologyMelanomaBase
Grant awards (45)
A High-Throughput Model for Human Melanoma$289,750
R01 · FY2025 · CA · contact PI
Cell Response and Regulation (CRR)$275,704
P30 · FY2025 · CA · contact PI
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program$268,514
T32 · FY2025 · CA
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program$303,786
T32 · FY2024 · CA
A High-Throughput Model for Human Melanoma$275,263
R01 · FY2024 · CA · contact PI
Cell Response and Regulation (CRR)$58,028
P30 · FY2024 · CA · contact PI
Exploiting the vulnerabilities in mutant IDH gliomas$333,594
R01 · FY2023 · NS · contact PI
A High-Throughput Model for Human Melanoma$289,750
R01 · FY2023 · CA · contact PI
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program$196,932
T32 · FY2023 · CA
Cell Response and Regulation (CRR)$72,331
P30 · FY2023 · CA · contact PI
Exploiting the vulnerabilities in mutant IDH gliomas$333,594
R01 · FY2022 · NS · contact PI
A High-Throughput Model for Human Melanoma$283,955
R01 · FY2022 · CA · contact PI
Cell Response and Regulation (CRR)$79,016
P30 · FY2022 · CA · contact PI
Exploiting the vulnerabilities in mutant IDH gliomas$333,594
R01 · FY2021 · NS · contact PI
A High-Throughput Model for Human Melanoma$289,750
R01 · FY2021 · CA · contact PI
Development of a new molecular predictor for risk of distant metastases in melanoma$142,588
R21 · FY2021 · CA · contact PI
Efficacy of combined inhibition of BRAF, MEK, and FAK in melanoma patient derived xenografts$125,000
R01 · FY2021 · CA · contact PI
Exploiting the vulnerabilities in mutant IDH gliomas$333,594
R01 · FY2020 · NS · contact PI
Development of a new molecular predictor for risk of distant metastases in melanoma$249,528
R21 · FY2020 · CA · contact PI
Exploiting the vulnerabilities in mutant IDH gliomas$333,594
R01 · FY2019 · NS · contact PI
A High-Throughput Model for Human Melanoma$247,340
R01 · FY2018 · CA · contact PI
A High-Throughput Model for Human Melanoma$247,340
R01 · FY2017 · CA · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$325,938
R01 · FY2016 · NS · contact PI
Defining the role of BRAF in glioma initiation and maintenance$325,938
R01 · FY2016 · NS · contact PI
A High-Throughput Model for Human Melanoma$247,340
R01 · FY2016 · CA · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$325,938
R01 · FY2015 · NS · contact PI
A High-Throughput Model for Human Melanoma$250,535
R01 · FY2015 · CA · contact PI
Defining the role of BRAF in glioma initiation and maintenance$322,678
R01 · FY2014 · NS · contact PI
A High-Throughput Model for Human Melanoma$250,535
R01 · FY2014 · CA · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$314,706
R01 · FY2013 · NS · contact PI
Defining the role of BRAF in glioma initiation and maintenance$314,530
R01 · FY2013 · NS · contact PI
A High-Throughput Model for Human Melanoma$59,552
R01 · FY2013 · CA · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$327,031
R01 · FY2012 · NS · contact PI
Defining the role of BRAF in glioma initiation and maintenance$326,940
R01 · FY2012 · NS · contact PI
Defining the role of BRAF in glioma initiation and maintenance$397,030
R01 · FY2011 · NS · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$386,786
R01 · FY2011 · NS · contact PI
Defining the role of mutant IDH in glioma initiation and maintenance$10,246
R01 · FY2011 · NS · contact PI
Defining the role of BRAF in glioma initiation and maintenance$1
R01 · FY2011 · NS · contact PI
A High-Throughput Model for Human Melanoma$179,400
R01 · FY2010 · CA · contact PI
A High-Throughput Model for Human Melanoma$10,200
R01 · FY2010 · CA · contact PI
A High-Throughput Model for Human Melanoma$513,524
R01 · FY2009 · CA · contact PI
A High-Throughput Model for Human Melanoma$208,080
R01 · FY2009 · CA · contact PI
A High-Throughput Model for Human Melanoma$189,600
R01 · FY2009 · CA · contact PI
A High-Throughput Model for Human Melanoma$189,600
R01 · FY2008 · CA · contact PI
A High-Throughput Model for Human Melanoma$229,100
R01 · FY2007 · CA · contact PI